Author: Jena, N. R.
Title: Drug targets, mechanisms of drug action, and therapeutics against SARS-CoV-2 Cord-id: ad758saa Document date: 2021_6_30
ID: ad758saa
Snippet: The recent outbreak of COVID-19 has affected human lives severely. The human-to-human transmission of this viral disease has become deadly due to the unavailability of COVID-19 specific drugs. Here, an overview of various attempts made to design different therapeutic agents against various structural and non-structural proteins of SARS-CoV-2 has been summarized. Emphasis has been made to highlight the mechanisms of drug action and ways to design better inhibitors of these proteins. The roles of
Document: The recent outbreak of COVID-19 has affected human lives severely. The human-to-human transmission of this viral disease has become deadly due to the unavailability of COVID-19 specific drugs. Here, an overview of various attempts made to design different therapeutic agents against various structural and non-structural proteins of SARS-CoV-2 has been summarized. Emphasis has been made to highlight the mechanisms of drug action and ways to design better inhibitors of these proteins. The roles of anti-oxidants and vitamins in suppressing COVID-19 are also discussed.
Search related documents:
Co phrase search for related documents- abnormal proportion and acute sars cov respiratory syndrome coronavirus: 1, 2, 3
- accessory protein and active site: 1, 2
- accessory protein and active site bind: 1, 2
- accessory protein and activity suppression: 1
- accessory protein and acute ards respiratory distress syndrome: 1
- accessory protein and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- accessory structural and active site: 1, 2
- accessory structural and active site bind: 1, 2
- accessory structural and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- accessory structural and adaptive immune response: 1
- accessory structural protein and active site: 1, 2
- accessory structural protein and active site bind: 1, 2
- accessory structural protein and acute sars cov respiratory syndrome coronavirus: 1, 2
- active site and acute ards respiratory distress syndrome: 1, 2
- active site and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- active site bind and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9
- activity suppression and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5
- actual function and acute kidney injury: 1
- acute ards respiratory distress syndrome and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
Co phrase search for related documents, hyperlinks ordered by date